MYRIAD GENETICS INC. - COMMON STOCK

Myriad Genetics Expands Board of Directors with Election of Paul M. Bisaro as New Board Member

31 окт 2022 16:30:00 Источник Nasdaq GlobeNewswire

Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022

26 окт 2022 16:05:00 Источник Nasdaq GlobeNewswire

Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds

28 сен 2022 09:00:01 Источник Nasdaq GlobeNewswire

Myriad Genetics Receives Expanded Coverage in Japan for Use of BRACAnalysis® Diagnostic System as a Companion Diagnostic for Lynparza® in Early-Stage Breast Cancer

25 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe

16 авг 2022 01:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Reports Second Quarter Financial Results

04 авг 2022 07:05:01 Источник Nasdaq GlobeNewswire

Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022

28 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics to Share Update on Business Transformation, Research and Development Pipeline, and Growth Plans at Investor Day on Aug. 11, 2022

19 июл 2022 17:07:33 Источник Nasdaq GlobeNewswire

Access to Myriad Genetics’ GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial

12 июл 2022 16:12:38 Источник Nasdaq GlobeNewswire

Myriad Genetics Issues Inaugural Environmental, Social and Governance Report

28 июн 2022 16:05:00 Источник Nasdaq GlobeNewswire